THE US Food and Drug Administration has announced new labelling requirements for anabolic steroid products including testosterone in an updated Abuse and Dependence section to include new safety information regarding the risks associated with abuse and dependence of testosterone and other anabolic androgenic steroids.
For details see www.fda.gov.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Oct 16
